Schroder Investment Management Group
VIR icon

Schroder Investment Management Group’s Vir Biotechnology VIR Stock Holding History

Schroder Investment Management Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-598,673
Closed -$3.5M – 1261
2025
Q4 		$3.5M Buy
598,673
+142,381
+31% +$848K ﹤0.01% 811
2025
Q3 		$2.57M Sell
456,292
-384,141
-46% -$1.96M ﹤0.01% 883
2025
Q2 		$4.24M Hold
840,433
– – ﹤0.01% 796
2025
Q1 		$5.63M Buy
+840,433
New +$7.47M 0.01% 739
2024
Q1 		– Sell
-47,000
Closed -$473K – 1248
2023
Q4 		$473K Buy
+47,000
New +$429K ﹤0.01% 1095
2023
Q3 		– Sell
-25,940
Closed -$636K – 1247
2023
Q2 		$636K Hold
25,940
– – ﹤0.01% 1097
2023
Q1 		$604K Sell
25,940
-8,592
-25% -$220K ﹤0.01% 1118
2022
Q4 		$874K Buy
34,532
+14,831
+75% +$364K ﹤0.01% 1066
2022
Q3 		$380K Buy
+19,701
New +$501K ﹤0.01% 1176

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return